Page last updated: 2024-10-30

metformin and Branch Vein Occlusion

metformin has been researched along with Branch Vein Occlusion in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Previous studies have found that metformin can reduce cardiovascular risk, but its association with retinal vein occlusion (RVO) is unknown."7.85Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study. ( Chen, SJ; Chiou, SH; Hsu, CC; Hwang, DK; Lin, TC; Peng, CH; Wang, ML, 2017)
"Previous studies have found that metformin can reduce cardiovascular risk, but its association with retinal vein occlusion (RVO) is unknown."3.85Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study. ( Chen, SJ; Chiou, SH; Hsu, CC; Hwang, DK; Lin, TC; Peng, CH; Wang, ML, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, TC1
Hwang, DK1
Hsu, CC1
Peng, CH1
Wang, ML1
Chiou, SH1
Chen, SJ1

Other Studies

1 other study available for metformin and Branch Vein Occlusion

ArticleYear
Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study.
    PloS one, 2017, Volume: 12, Issue:11

    Topics: Aged; Diabetes Complications; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Ret

2017